Muell. Arg. is widely used in Brazilian folk medicine to treat diabetes and venereal diseases. This study examined the acute toxicity and cytotoxicity of the essential oil of C. argyrophylloides (EOCA). In addition, vascular effects of the EOCA have been examined. In mice, an oral acute toxicity test revealed that EOCA could be considered as a non toxic essential oil since it showed a very high LD 50 (9.84 ± 0.01 g/kg). In the brine shrimp (Artemia salina) cytotoxic assay, the LC 50 value of EOCA was 275 [165-534] µg/mL. EOCA (1-1000 µg/mL) relaxed isolated endothelium-intact aortic rings precontracted with phenylephrine with an IC 50 value of 126.7 [89.8-163.7] µg/mL. In rat mesenteric bed preparations precontracted with phenylephrine, EOCA (1-300 µg/mL) also induced a reversible, vasodilator effect with an IC 50 value of 46.0 [33.3-58.7] µg/mL. It is concluded that EOCA is a very interesting agent from the point of view of the possibility of therapeutic application. This is because, whilst showing a very small acute toxicity, EOCA also showed maximal efficacy as a vascular antispasmodic agent with a pharmacological potency similar to that of other Croton species essential oils.
The genus Croton comprises about 1000 species, distributed mostly throughout the American continent. In Brazil, there are 300 Croton species, predominantly in the northeastern region [6] . It has been previously shown that essential oils of Croton species bear two characteristics: they have a variety of pharmacological effects and small acute toxicity [7] . Amongst these effects, hypotensive and antispasmodic activities of the essential oils of C. nepetaefolius, C. zehntneri and C. sonderianus on several types of smooth muscle [9] [10] [11] [12] [13] [14] , as well as acaricidal activity against Tetranychus urticae of the essential oils of C. jacobinensis and C. rhamnifolius [15] have been reported previously. Furthermore, in vitro antileishmanial, larcidical and cruzain inhibitory activities have been reported for essential oils of C. macrostachyus, C. zehntneri and C. draco, respectively [16] [17] [18] . However, no literature information is available regarding putative vasorelaxant effects of EOCA. To address this issue, the present study was performed in rat isolated thoracic aorta and mesenteric vascular bed preparations. Additionally, acute toxicity and cytotoxicity of EOCA have been evaluated. Table 1 shows the effects of different concentrations of EOCA against nauplii of A. salina. The LC 50 value obtained was 275 [165-534] µg/mL, which indicates low or no toxicity (LC 50 > 250 µg/mL, according to [19] ). No death was observed at 1 g/mL, while death percentage reached 70% at 1000 g/mL EOCA (Table  1) . Negative controls containing sea water solution with Tween 80 (1%) showed a death percentage (6.6%) similar to that observed in tubes containing only sea water. EOCA, administered orally to mice at 5 or 8 mg/kg, did not show any mortality in the 72 h-period of observation. However, administration of higher doses of EOCA (10 and 14 mg/kg) induced the death of 67 and 83% of the animals, respectively. The LD 50 value was 9.84 ± 0.01 g/kg body weight, indicating that the essential oil is non-toxic to mammals. Upon administration of 14 g/kg of EOCA, some animals died in the first 30 min after gavage, but the survivors improved 24 h after gavage of this dose. The steady-state value of the phenylephrine (PHE)-induced contraction was 1.46 ± 0.13 g (80% of the contraction evoked by 75 mM of K + ). The cumulative addition of EOCA (1-1000 g/mL, n = 6), but not its vehicle (n = 6), produced a reversible and concentration-related vasorelaxant response (P < 0.001, one-way ANOVA) in rat aortic rings with intact endothelium pre-contracted with 1 M PHE ( Figure 1) , with an IC 50 value corresponding to 126.7 [89. 8-163.7 ] g/mL. The inhibitory effect of EOCA became significant at a concentration of 60 g/mL ( Figure 1 ; P < 0.05, ANOVA and Holm-Sidak tests).
Under constant pressure (50 mm Hg), rat mesenteric bed perfused with a solution containing a normal K + concentration (4.7 mM) showed a control flow of 6.10 ± 0.64 mL/min (n = 7). Perfusion of the mesenteric bed with KHB buffer containing PHE (10 µM) produced a vasoconstrictor response, as occurred a significant reduction (P < 0.001, paired Student's t-test) of the control mesenteric flow to a value of 1.52 ± 0.19 mL/min (n = 7), which correspond to a reduction of 74.10 ± 2.54% of the control flow 100 and 300 g/mL of EOCA, the mesenteric flow was increased to a value corresponding to 65.44 ± 11.21 and 71.20 ± 10.41% of the control flow ( Figure 3 ). The major finding of this study is that EOCA, whilst showing absence of acute toxicity, according to toxicity classification of essential oils, it also showed maximal efficacy as a vascular antispasmodic agent with a pharmacological potency similar to many other essential oils of plants belonging to the Croton genus. These promising findings are reported for the first time.
In this study, toxicity of EOCA was evaluated. In the brine shrimp (Artemia salina) cytotoxic assay, the LC 50 value of EOCA was 275 [165-534] µg/mL, indicating low or no cytotoxicity. Confirmation of this non acute toxicity came from data obtained in vivo. In mice, the very high LD 50 (9.84 ± 0.01 g/kg) of EOCA administered per os clearly demonstrated no acute toxicity. In fact, according to a classification of the safety of essential oils used in aromatherapy [20] , those exhibiting a LD 50 value greater than 5 g/kg are considered as non-toxic to rodents.
The essential oils of several Croton species with documented pharmacological efficacy have had their oral acute toxicity determined. They have shown low toxicity, but none was non toxic according to the aromatherapy toxicity criteria [20] , as was the case for EOCA. For instance, the essential oils of C. nepetaefolius (EOCN) and C. zehntneri (EOCZ) had LD 50 values ranged between 2 and 4 g/kg [8, 21, 22] . Essential oils with values between 2.00 and 4.99 g/kg are classified as having low toxicity. Taken together, the present toxicological studies indicate that EOCA exhibited no acute toxicity and had no cytotoxicity. It is thus noteworthy that EOCA is the first essential oil from northeastern Brazil to fall into the non toxic category of aromatherapy.
In vitro experiments showed for the first time that EOCA (10-1000 µg/mL), in a concentration-dependent manner, fully relaxed the isolated endothelium-intact aortic rings precontracted with PHE. At the same range of concentration, EOCN [9] and EOCZ [12] induced vasorelaxant effects in PHE-precontracted aortic ring preparations with intact endothelium from normotensive rats. This similarity includes not only the type of effect but also the efficacy and pharmacological potency. In fact, the IC 50 value for the relaxant effect of the EOCA obtained in the present study (126.7 µg/mL) is of the same order of magnitude as that obtained with either EOCN (112.9 µg/mL) [9] or EOCZ (185.6 µg/mL) [12] under the same experimental conditions. Our previous studies showed that oral treatment with EOCN and EOCZ exhibited an in vivo pharmacological efficacy in the dose range between 30 and 300 mg/kg [21, 22] . If the similarity between EOCA, EOCN and EOCZ for pharmacological potency in vitro will hold in in vivo experiments, then EOCA is expected to have a very favorable therapeutic index.
At 100 and 300 µg/mL, EOCA was also able to revert partially, but significantly, the reduction of mesenteric flow caused by PHE in mesenteric bed preparations maintained under constant pressure with an IC 50 value of 42.7 [4.8-161.8] µg/mL. This effect, which is indicative of vasodilatation, was reversible after washout.
Vasodilator effects of EOCA in both a conduit artery and a resistance vascular bed preparation could be responsible for a putative hypotensive action of this essential oil, as previously demonstrated for EOCN [9] and EOCZ [12] in normotensive rats. As no information in the international literature is available regarding this hypothesis, experiments are underway in our laboratory to test such a possibility and also to elucidate the mechanisms underlying the vasorelaxant effects of EOCA. Based on the present toxicological data, it is highly unlikely that these Toxicological and vasorelaxant effects of EOCA Natural Product Communications Vol. 7 (10) 2012 1399 vasorelaxant effects of EOCA, which were reversible, could be related to a putative toxic effect of this essential oil.
Chemical analysis of the sample of EOCA used in the present investigation identified twelve compounds, the major ones being spathulenol (26.6%), caryophyllene oxide (13.1%), β-elemene (12.1%), and β-caryophyllene (10.9%). Further studies are needed to identify the active principle(s) responsible for the vasorelaxant effects of EOCA. In conclusion, the present study showed that the EOCA is a very interesting agent from the point of view of possible therapeutic application. This is because, whilst showing a very small acute toxicity, but classifiable as a non-toxic agent, EOCA also showed maximal efficacy as a vascular antispasmodic agent with a pharmacological potency similar to that of many other Croton species essential oils. In view of these promising results, further in vivo studies with EOCA must be performed. All procedures described here were reviewed by and had prior approval from the local Animal Ethics Committee (State University of Ceará, process number 06379067-0).
Experimental

Evaluation of acute toxicity of OECA:
Mice were randomly divided into one control and 4 treatment groups (n = 6 per group).
Test groups were treated orally with a single dose of EOCA at 5, 8, 10 or 14 g/kg. The stock solution was prepared by mixing EOCA, Tween 80, and distilled water. The control group received only an equal volume (0.1 mL/10g body weight) of vehicle (distilled water and Tween 80) by the same route. Animals were maintained in a cage with free access to food and water. Besides the number of deaths, general behavior was recorded for 3 consecutive days. Lethality, evaluated by means of LD 50 , representing the lethal dose of oil per unit weight which kills 50% of the population of test animals, was calculated by probit analysis [23c].
Toxicity testing of EOCA against brine shrimp:
The brine shrimp (Artemia salina) lethality test was performed according to a previously described method [24] , with some modifications. Eggs of A. salina were incubated in sea water, aerated at 25°C under artificial light for 3 days for egg hatching. Then, the hatched nauplii were collected by filtering the culture medium and transferred to tubes containing different concentrations of EOCA (1-1000 µg/mL, in triplicates) (10 nauplii/tube). EOCA was dissolved in sea water with Tween 80 (1%). Control tubes (negative control) contained only sea water solution with Tween 80 (1%). Tubes were incubated under artificial light at 29°C. Forty eight h later, the number of dead nauplii was counted. Toxicity was evaluated by means of LC 50 (lethal concentration to 50% of the animals), which was calculated using Probit analysis with 95% confidence intervals [23b]. According to [19] : LC 50 < 80 µg/mL was considered highly toxic; between 80 µg/mL and 250 µg/mL, moderately toxic; LC 50 > 250 µg/mL, low toxicity or non toxic.
Measurement of the aortic contractile activity:
Rats were sacrificed by cervical dislocation. Thoracic aortae were removed and immersed in KHB buffer at room temperature. After removing adhering fat and connective tissue, the aorta was cut transversally into cylindrical ring-like segments (4-5 mm) attached to steel wire triangular pieces (0.3 mm diameter), which were mounted in 5 mL organ baths containing perfusion medium continuously bubbled with 95% O 2 and 5% CO 2 at 37°C. Endothelium-containing strips were stretched with a passive tension of 1 g and tension was recorded using an isometric force transducer (Grass Model FTO3, Quincy, MA, USA) connected to a PC based data acquisition system. After an equilibration period of at least 45-60 min, control contractions were induced by adding a submaximal concentration (75 mM) of potassium chloride (KCl) to the bath. When 2 successive control contractions showed similar amplitudes, preparations were considered to be equilibrated. Each isolated aortic preparation was challenged at the beginning of the experiment with 10 M of acetylcholine. Preparations were considered to possess an intact endothelium, when the vasorelaxant response to acetylcholine was greater than 80% of PHE-induced contraction. To assess the vasorelaxant effects of EOCA, preparations were exposed during a 5-min period to increasing concentrations (1-1000 g/mL, n = 6) of EOCA, once a sustained contraction elicited by PHE (1 M) had been established. EOCA or vehicle (n = 6) was directly added to the buffer solution in a cumulative manner.
Measurement of the mesenteric bed flow:
Rats were sacrificed by cervical dislocation. The superior mesenteric artery was identified and cannulated. The cannulated artery and its vascular bed were dissected out and mounted in an organ device developed in our laboratory. Thereafter, the entire mesenteric vascular bed was perfused at a constant hydrostatic pressure of 50 mmHg with KHB buffer continuously bubbled with 95% O 2 and 5% CO 2 at 37°C. Changes in the vascular resistance were measured by comparing perfusion flow before and after drug administration. As constant pressure was maintained by regulating the height of the liquid column in order to achieve always a pressure corresponding to 50 mmHg, changes in the vascular resistance of the perfused bed were inversely proportional to changes in the perfusion flow. An equilibration period of 30 min was allowed to stabilize the baseline perfusion flow of the mesenteric vascular bed. In control experiments, this was followed by PHE (10 mM, n = 7) perfusion for 15 min. This was done because a preconstriction is required to induce vasodilation [25] . In the experimental group, 15 min after the beginning of perfusion with PHE, the response to a single concentration (1-300 g/mL, n = 3-7) of EOCA was studied. A washout was then allowed until the baseline flow rates were achieved.
Statistical analysis:
Data are expressed as mean ± SEM. Peak deflection of the contraction after each concentration of EOCA or vehicle was used to construct a concentration-response curve, and was expressed as a percentage of control contraction to the contractile agent PHE obtained in the absence of EOCA. The IC 50 value, defined as the EOCA concentration (g/mL) required to produce half maximum reduction of PHE-induced contraction, was used to evaluate vascular sensitivity to EOCA. It was calculated by interpolation from semi-logarithmic plots and expressed as geometric means (95% confidence interval). The significance (P < 0.05) of the results was assessed by means of paired Student´s t-test, one-or two-way analysis of variance (ANOVA), followed respectively by Holm-Sidak multiple comparison tests when appropriate.
